Table 1

 Baseline characteristics of the patients*

VariableNo of patients (n = 29)
CDAI, Crohn’s disease activity index; 6-MP, 6-mercaptopurine.
Sex (M/F)13/16 (44.8% M)
Mean age (y)34.0 (10.8)
Smoking status (yes/total)9/29 (31%)
Initial CDAI296.7 (46.9)
Median duration of disease (y)4 (1.5–8)
Site of disease
    Small bowel only10/29 (34.5%)
    Colon only5/29 (17.2%)
    Small bowel and colon14/29 (48.3%)
Ileal resection5/29 (17.2%)
Medications at entry
    No medications5/29 (17.2%)
    Mesalamine10/29 (34.5%)
    Corticosteroid3/29 (10.3%)
    Azathioprine3/29 (10.3%)
    Mesalamine+corticosteroid1/29 (3.4%)
    Mesalamine+azathioprine/6-MP1/29 (3.4%)
    Corticosteroid+azathioprine/6-MP3/29 (10.3%)
    Mesalamine+corticosteroid+azathioprine/6-MP3/29 (10.3%)